FDA approves emergency booster dose of Moderna’s COVID-19 vaccine
October 15, 2021Medical Communications
The FDA Advisory Committee has unanimously voted in support of emergency use for a booster dose of Moderna’s COVID-19 vaccine …
EMA begins real-time review of AstraZeneca’s COVID antibody cocktail
October 15, 2021Medical Communications
The human medicines committee of the EMA has begun the rolling review of AstraZeneca’s antibody-based COVID-19 therapy, the first protective …
Abbott Labs recalls two COVID test kits after false positives
October 15, 2021Medical Communications
A unit of Abbott Laboratories is recalling two COVID-19 lab test kits over concerns they can potentially issue false positives, …
Anticancer Bioscience receives additional $10.6m investment into cancer therapy
October 14, 2021Business Services
Precision oncology company, Anticancer Bioscience (ACB), has announced that it has secured an additional $10.6 million from Chinese investors. The …
Lexeo Therapeutics and FUJIFILM announce partnership to co-develop gene therapies
October 14, 2021Business Services
LEXEO Therapeutics, clinical-stage gene therapy company, and FUJIFILM Diosynth Biotechnologies, world leading CDMO for biologics, viral vaccines and viral vectors, …
WHO’s new taskforce “last chance” to track COVID origins
October 14, 2021Business Services
The WHO has put together a new taskforce, the Scientific Advisory Group on the Origins of Novel Pathogens (Sago), with …
UCL: Lateral flow test more accurate than previously thought
October 14, 2021Business Services
Researchers from University College London (UCL) have been studying the accuracy of lateral flow tests (LFTs), and have found them …
Verona Pharma to present Phase II data with pMDI for COPD patients
October 13, 2021Research and Development
Clinical-stage biopharmaceutical company, Verona Pharma plc (Verona), is due to present Phase II data demonstrating the positive effect of a …
Empagliflozin (Jardiance®) receives SMC approval for treatment of heart failure
October 13, 2021Research and Development
The Scottish Medicines Consortium (SMC) has announced that empagliflozin (Jardiance®) has been accepted for use by NHS Scotland, for the …
Gavi to purchase 176.5 million doses of Moderna COVID-19 vaccine for low income countries
October 13, 2021Research and Development
COVAX has purchased more than 210 million doses of their vaccine for delivery to low income countries. This supply agreement …
Symbiosis Pharma to manufacture Modus’ sepsis treatment
October 12, 2021Manufacturing and Production
Modus Therapeutics, a company developing pharmaceutical therapies for diseases with high unmet medical need, has announced that Symbiosis Pharmaceutical Services …
Investment into mid-stage tech companies reaches new heights
October 12, 2021Manufacturing and Production
31 companies have been accepted into Tech Nation’s Upscale growth programme for fast growing, mid-stage (Series A) scaling tech companies. …
SMC announces first long-acting injectable HIV treatment
October 12, 2021Manufacturing and Production
The Scottish Medicines Consortium (SMC) has approved the first long-acting injectable regimen for people living with HIV in Scotland, manufactured …
AstraZeneca’s antibody cocktail cuts risk of severe COVID in half, study finds
October 12, 2021Manufacturing and Production
AstraZeneca’s antibody cocktail against COVID-19, which has proven to work as a preventative shot in the non-infected, has been successful …
UK government COVID response “one of UK’s worst ever public health failures”, inquiry finds
October 12, 2021Manufacturing and Production, Medical Communications
A 150-page report published on Tuesday by the House of Commons, Science and Technology Committee, and Health and Social Care …
SparkRx depression therapeutic shown to cut depression symptoms in adolescents
October 11, 2021Sales and Marketing FDA, Limbix, SparkRx
A new digital therapeutic available for use without prescription under the FDA’s emergency guidance for digital health devices has shown …
NICE approves treatment for rheumatoid arthritis
October 11, 2021Sales and Marketing
NICE has issued a positive final appraisal document recommending upadacitinib, a once-daily oral therapy, for people with previously treated moderate …
Two Indian drugmakers to discontinue MSD’s molnupiravir
October 8, 2021Medical Communications
AuroBindo Pharma Ltd and MSD Laboratories plan to end their respective trials of MSD’s experimental antiviral drug molnupiravir in moderate …
Samsung Biologics partners with Enzolytics Inc for antibody therapies
October 8, 2021Medical Communications
Leading manufacturing organisation Samsung Biologics, alongside drug development company Enzolytics, have announced the signing of a strategic CDMO partnership agreement. …
Talem Therapeutics and Pierre Fabre to form antibody research collaboration
October 8, 2021Medical Communications
Talem Therapeutics, subsidiary of Immunoprecise Antibodies Ltd (IPA), and the Pierre Fabre pharmaceutical group have announced a multi-target research collaboration, …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
